Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Landsbankinn hf.: Covered bond exchange offering results
-
XMax to Acquire Hexa Creation, Developer of 1200V Vertical GaN Power Semiconductor Technology
-
Frontline Education and AI for Education Win Two Tech & Learning Best for Back to School Awards
-
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
-
Carpenter Technology Declares Quarterly Cash Dividend
-
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
-
Black Rock Coffee Bar Continues Austin-Area Growth with New Killeen Location
-
GoldHaven Intersects Skarn 80 Metres from Prior Deep Skarn Intercept at Kuhn, Strengthening Evidence for Continuity
-
Stride to Appoint Steven Guttentag and Dylan Haggart to Board of Directors and Form Capital Allocation Committee
-
CENTEL Announces Masternode Participation Model and Blockchain Development Roadmap
-
VCI Global Clarifies Structure of US$125 Million Standby Equity Purchase Facility, Emphasizes Flexible Capital Strategy
-
Rezolve Ai Opens Retail to Any AI Shopping Agent with RezolvePay, Targeting a Multi-Trillion-Dollar Commerce Opportunity
-
New Crypto: Pepeto Announces Its Presale Passing $11 Million, With the BNB Price Prediction Now at $2,775
-
GF unveils roadmap to deliver the world’s most advanced FD-SOI platform for Physical AI
-
Frontline Education and AI for Education Win Two Tech & Learning Best for Back to School Awards
-
Nextech Unveils Agentic AI Capabilities for Patient Experience through Partnerships with Assort Health and EliseAI
-
AssetBuilt Announces Major U.S. Industrial Asset Sales Featuring Cutrale Florida, Aspen Aerogels Georgia, Jindal Films Oklahoma, Mil-Spec Los Angeles, R3 Lithium and Fortune 500 EV Manufacturing Asset
-
Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences
-
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
-
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
-
OFA Group Completes Acquisition and Title Registration of Tokawa Coastal Property in Choshi, Japan
-
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
-
Fiverr to Release Third Quarter 2026 Results on October 29, 2026
-
New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia
-
Man Group PLC : Form 8.3 - RHI Magnesita N.V.
-
Man Group PLC : Form 8.3 - Vesuvius Plc
-
Man Group PLC : Form 8.3 - Sthree plc
-
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
-
MEXC and Payward Highlight Collaboration as Crypto and TradFi Converge at TOKEN2049
-
Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
What is SGI: Centralized Super Intelligence Governance Platforms to Stop ‘Skynet Scare’ (Veterans First for America)
-
VenHub Highlights Continued Expansion of Intellectual Property Program
-
Chemtrade Logistics Income Fund Announces Plans for Conversion to A Simplified New Corporate Structure to Support Long Term Growth
-
Watsco Schedules Third Quarter Conference Call On Tuesday, October 27, 2026 at 10:00 a.m. (EDT)
-
King Copper Selects Drill Contractor for Inaugural Drill Program at Colquemayo
-
Aura Announces Preliminary Record High Production in Q3 2026 and 9M 2026 Production Results
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Auction result of Treasury Bonds - RIKB 29 0416 - RIKB 38 0215
-
Women Legislators in 16 States Unite to Close ‘Voluntary Intoxication’ Loophole That Fails Sexual Assault Survivors
-
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
-
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical D
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Aurora Mobile’s JPush Strengthens Shennong Group’s Messaging Infrastructure to Support Timely Delivery of Critical Business Information
-
Wrap Appoints Veteran Law Enforcement Leader John “Chappy” Chapman as Vice President of Training and Missions
-
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermat
-
Overmatch Ventures announces first annual Austin Deep Tech 50


